Immunohistochemical
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using BCL-2 (Phospho-Ser70) Antibody. The picture on the right is treated with the synthesized peptide.Western blot
Western blot analysis of extracts from HeLa cells treated with LPS (40nM, 30mins), K562 cells treated with calyculin A (50ng/ml, 30mins) and COS-7 cells treated with H2O2 (1ng/ml, 15mins), using BCL-2 (Phospho-Ser70) Antibody. The lane on the right is treated with the synthesized peptide| Product Name | Rabbit anti-BCL-2 (Phospho-Ser70) polyclonal antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | The antiserum was produced against synthesized peptide derived from human BCL-2 around the phosphorylation site of Ser70. |
| Modification | p-Ser70 |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | WBIHCIPELISA |
| WB:1:500~1:1000 IHC:1:50~1:100 ELISA:1:10000 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | BCL2 |
|---|---|
| Gene Synonyms | Apoptosis regulator Bcl-2 B-cell CLL/lymphoma 2 BCL2 |
Immunohistochemical
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using BCL-2 (Phospho-Ser70) Antibody. The picture on the right is treated with the synthesized peptide.
Western blot
Western blot analysis of extracts from HeLa cells treated with LPS (40nM, 30mins), K562 cells treated with calyculin A (50ng/ml, 30mins) and COS-7 cells treated with H2O2 (1ng/ml, 15mins), using BCL-2 (Phospho-Ser70) Antibody. The lane on the right is treated with the synthesized peptide| Application Notes | WB:1:500~1:1000 IHC:1:50~1:100 ELISA:1:10000 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
